Clinical Trials Directory

Trials / Completed

CompletedNCT00916994

Prospective Study for Safety and Efficacy of InSpace™ in Rotator Cuff Tear Subjects

One-arm, International, Multi-center With Competitive Recruitment, Prospective Study to Assess the Safety and Efficacy of OrthoSpace's InSpace™ in Rotator Cuff Tear Subjects Scheduled for Surgery of the Rotator Cuff

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
58 (actual)
Sponsor
OrthoSpace Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Title: One-arm, international, multi-center with competitive recruitment, prospective study to assess the safety and efficacy of OrthoSpace's InSpace™ in rotator cuff tear subjects scheduled for surgery of the rotator cuff - A pivotal study Device: OrthoSpace's Biodegradable Implanted Balloon (InSpace) Study population: Rotator Cuff tear subjects scheduled for arthroscopy. Number of subjects: Up to 70 subject for data analysis. Number of sites: At least 4 sites in Israel. Main Inclusion criteria: Informed consent, diagnosed with Rotator Cuff tear. Main Exclusion criteria: Former surgery on affected shoulder, sever illness, significant shoulder co morbidities. Follow up period: 12 months. Visits at hospital before discharge at 1-2 days post implantation, 7-10 days post implantation, 3 weeks post implantation, 6 weeks post implantation, 3,6 and 12 months post implantation. Primary goal: To assess the safety of the SpaceGuard in Rotator Cuff tear subjects. Secondary goals: To assess the effectiveness of the SpaceGuard in the study population. The effectiveness will be assessed by terms of good positioning of the SpaceGuard and subsequent follow-up non migration, surgeon satisfaction, pain relief and time to pain relief, Range of Motion (ROM) and time to ROM with the SpaceGuard. Primary end point: Serious Adverse Event rate related to the device and/or system complication. Secondary end points: Surgeon dissatisfaction following the deployment of SpaceGuard, migration of the balloon shown by ultrasound/ X-ray/MRI at relevant follow-up visits, lost of ROM and pain enhancement.

Detailed description

The OrthoSpace's InSpace™ biodegradable sub-acromial spacer (balloon) will be inserted at the end of the routine arthroscopy between the humerus head and the acromion.

Conditions

Interventions

TypeNameDescription
DEVICESpaceGuard BalloonPositioning of the balloon into the subacromial space between the humerus head and the acromion

Timeline

Start date
2009-07-01
Primary completion
2014-04-01
Completion
2014-06-01
First posted
2009-06-10
Last updated
2015-03-11

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT00916994. Inclusion in this directory is not an endorsement.